As a result, SPP1 showed higher expression in brain cancer, bladder cancer, cervical cancer, CRC, esophageal carcinoma (ESCA), GC, HNC, kidney cancer, liver cancer, LC, lymphoma, melanoma, PCa and pancreatic cancer in comparison with non-carcinoma tissues. Here, SPP1 is linked to urinary bladder cancer.